Moderna Stock News

Shares of Moderna Inc. undefined were down 0.5% in premarket trading on Wednesday after the company said it began dosing participants in a Phase 1 clinical

After dropping from record highs in August 2021, now may be a good time to assess Moderna''s long-term value.

The winners on the first trading day of 2021 mostly went on to outperform the S&P 500. The losers did not.

The number is roughly in line with company estimates, but the stock keeps falling.

Moderna Inc. said in a letter to shareholders disclosed Tuesday, Chief Executive Stéphane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-19 vaccine to more than 60 countries in 2021, and more than tripled the amount of cash and cash equivalents it held. Meanwhile, the stock dropped 1.2% in premarket trading, after dropping 7.5% on Monday, and tumbling 27.9% in December. Bancel said the company had more than $17 billion in cash and cash equivalents at the end of 2021, after entering the year with about $5.25 billion. The company said it was working with the U.S. Food and Drug Administration to have its COVID-19 vaccine authorized for 12 to 17 year olds, as it is already authorized in more than 10 countries and the European Union. Separately, Bancel said Moderna''s flu vaccine has showed "positive" interim Phase 1 data, its vaccine for respiratory syncytial virus (RSV) moved to a Phase 2/3 trial and that its Personalized Cancer Vaccine Phase 2 trial is fully enrolled with a readout expected as early as the fourth quarter of 2022.

Both of these coronavirus vaccine innovators have plenty of upside in 2022.

Vaccines have saved lives and prevented severe disease, with comparatively few adverse events. But, anti-vaccine groups persistently refer to mRNA vaccines as experimental gene therapies. Vaccines that use mRNA technology, however, aren''t gene therapies as they don''t alter a persons genes.

Moderna Inc''s (NASDAQ: MRNA ) short percent of float has risen 4.8% since last its last report. The company recently reported that it has 15.29 million shares sold short , which is 4.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.1 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price Full story available on Benzinga.com

Waldron Private Wealth LLC acquired a new position in Moderna, Inc. (NASDAQ:MRNA) in the 3rd quarter, HoldingsChannel reports. The firm acquired 920 shares of the companys stock, valued at approximately $354,000. Several other institutional investors also recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. raised its stake in shares of []

Perigon Wealth Management LLC boosted its position in Moderna, Inc. (NASDAQ:MRNA) by 17.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,359 shares of the company’s stock after acquiring an additional 204 shares during the period. Perigon Wealth Management LLC’s holdings […]

Related Stocks: TMUS , JCI , NOC , JNJ , ISRG , IRWD , INTU , BAC , AMD , ORLY , MRNA , VNO , ATVI , NXPI , COST , ON , BIIB , LLY , AMAT , DG , BRK.B , BXP , ICE , HIG ,

If you''re eligible for a COVID-19 vaccine booster shot, you don''t have to stick with the same company that manufactured your primary dose(s).

SVB Leerink restated their sell rating on shares of Moderna (NASDAQ:MRNA) in a research report sent to investors on Thursday morning, AnalystRatings.com reports. Other equities analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Moderna in a research note on Friday, October 22nd. They issued a []

Related Stocks: RBLX , SNOW , KINVB , U , TTD , GBTC , BILL , CZOO , DDOG , GH , IS , ZI , SPOT , VEEV , EVO , MRNA , OKTA , COUP , APT , ISRG ,

Related Stocks: MRNA ,